Jane Street’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-80,874
| Closed | -$1.21M | – | 10610 |
|
|
2022
Q4 | $1.21M | Buy |
+80,874
| New | +$1.12M | ﹤0.01% | 4675 |
|
|
2022
Q2 | – | Sell |
-13,228
| Closed | -$74K | – | 11533 |
|
|
2022
Q1 | $74K | Buy |
+13,228
| New | +$54.5K | ﹤0.01% | 9564 |
|
|
2021
Q3 | – | Sell |
-32,563
| Closed | -$195K | – | 11294 |
|
|
2021
Q2 | $214K | Sell |
32,563
-2,454
| -7% | -$16.9K | ﹤0.01% | 8713 |
|
|
2021
Q1 | $256K | Buy |
+35,017
| New | +$302K | ﹤0.01% | 7921 |
|
|
2020
Q4 | – | Sell |
-35,912
| Closed | -$213K | – | 8539 |
|
|
2020
Q3 | $213K | Buy |
35,912
+19,600
| +120% | +$97K | ﹤0.01% | 6356 |
|
|
2020
Q2 | $84K | Buy |
+16,312
| New | +$103K | ﹤0.01% | 6765 |
|
|
2019
Q4 | – | Sell |
-5,543
| Closed | -$47K | – | 6120 |
|
|
2019
Q3 | $47K | Sell |
5,543
-8,982
| -62% | -$66.8K | ﹤0.01% | 4896 |
|
|
2019
Q2 | $98K | Buy |
+14,525
| New | +$124K | ﹤0.01% | 4860 |
|
|
2018
Q1 | – | Sell |
-2,855
| Closed | -$80K | – | 5719 |
|
|
2017
Q4 | $80K | Buy |
2,855
+1,454
| +104% | +$45.1K | ﹤0.01% | 4368 |
|
|
2017
Q3 | $51K | Sell |
1,401
-6,868
| -83% | -$212K | ﹤0.01% | 4333 |
|
|
2017
Q2 | $184K | Buy |
+8,269
| New | +$65.1K | ﹤0.01% | 4056 |
|
|
2015
Q2 | – | Sell |
-7,547
| Closed | -$109K | – | 4240 |
|
|
2015
Q1 | $109K | Buy |
+7,547
| New | +$82.5K | ﹤0.01% | 2993 |
|
|
2013
Q3 | – | Sell |
-4,697
| Closed | -$117K | – | 3295 |
|
|
2013
Q2 | $117K | Buy |
+4,697
| New | +$201K | ﹤0.01% | 2404 |
|
Jane Street's AVEO Position: Q1 2023 in Review
Jane Street sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 80,874 shares — an estimated $1.21M sold.
Jane Street first reported a position in AVEO in Q2 2013 and held it in 13 quarters. The position peaked at $1.21M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Jane Street reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Jane Street sold 80,874 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.21M.
- Jane Street first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
- Jane Street's AVEO Pharmaceuticals, Inc. position peaked at $1.21M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.